Two Fort Lauderdale-based attorneys took a Boca Raton health care company public last month despite the nation’s slumping initial public offering market.
Robert Lamm and David Scileppi with Gunster’s securities and corporate governance team advised Sensus Healthcare Inc. for seven months before successfully pricing its IPO in early June. The medical device company, which focuses on treating nonmelanoma skin cancers, is now listed on the Nasdaq under the SRTSU symbol.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
